Marina Ravizza

Minimal prevalence of HPV vaccination and common occurrence of high-risk HPV types in pregnant women with HIV: data from a national study in Italy

Marco Floridia, Giulia Masuelli, Beatrice Tassis, Valeria Maria Savasi et autres

it (code pays fourni par la source)

Predictors of low ovarian reserve in cART-treated women living with HIV

Esther Merlini, Camilla Tincati, Valentina Sacchi, Matteo Augello et autres

ABSTRACT: Ovarian dysfunction and lower circulating anti-Müllerian hormone (AMH) feature women living with HIV (WLWH). Because treated human immunodeficiency virus (HIV) infection is characterized by a pro-inflammatory/oxidative phenotype resulting in residual comorbidity, we sought to investigate possible associations between plasma AMH and …

it, us (code pays fourni par la source)

CD4/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy

Marco Floridia, Carmela Pinnetti, Giulia Masuelli, Arsenio Spinillo et autres

it (code pays fourni par la source)

Prevalence, Correlates and Outcomes of Smoking in Pregnant Women with HIV: A National Observational Study in Italy

Marco Floridia, Marina Ravizza, Giulia Masuelli, Beatrice Tassis et autres

Background: Few studies have evaluated in pregnant women with HIV the prevalence of smoking and its associations with maternal and neonatal outcomes. Objectives: to assess the prevalence of smoking among women with HIV in early pregnancy and the association between smoking and …

it (code pays fourni par la source)

Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study

Marco Floridia, Serena Dalzero, Vania Giacomet, Enrica Tamburrini et autres

it (code pays fourni par la source)

PREGNANCY LOSS IN WOMEN WITH HIV IS NOT ASSOCIATED WITH HIV MARKERS: DATA FROM A NATIONAL STUDY IN ITALY, 2001-2018

Marco Floridia, Giulia Masuelli, Beatrice Tassis, Enrica Tamburrini et autres

BACKGROUND: There is limited information on pregnancy loss in women with HIV, and it is still debated whether HIV-related markers may play a role.Objectives: To explore potential risk factors for pregnancy loss in women with HIV, with particular reference to modifiable risk …

it (code pays fourni par la source)

Weight Gain during Pregnancy in Women with HIV Receiving Different Antiretroviral Regimens

Marco Floridia, Giulia Masuelli, Beatrice Tassis, Laura Franceschetti et autres

Background No published studies have evaluated in pregnant women with HIV weight gain with different antiretroviral drug classes. Methods Data from a national cohort study were used. We compared absolute weight gain and occurrence of excessive weight gain in women with HIV …

it (code pays fourni par la source)

Vaginal delivery in women with HIV in Italy: results of 5 years of implementation of the national SIGO-HIV protocol

Cecilia Tibaldi, Giulia Masuelli, Matilde Sansone, Beatrice Tassis et autres

it (code pays fourni par la source)

Brief Report: Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women With HIV: Laboratory and Clinical Outcomes in an Observational National Study

Marco Floridia, Carmela Pinnetti, Marina Ravizza, Giulia Masuelli et autres

BACKGROUND: Abacavir-lamivudine (ABC/3TC) and tenofovir-emtricitabine (TDF/FTC) represent in the guidelines of several countries, including Italy and United States, the preferred nucleoside/nucleotide backbones of antiretroviral regimens. We assessed their profile in pregnancy using data from a national observational study. METHODS: Laboratory measures (CD4, …

it (code pays fourni par la source)

Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study

Marco Floridia, Giulia Masuelli, Marina Ravizza, Beatrice Tassis et autres

Background: Atazanavir and darunavir represent the main HIV PIs recommended in pregnancy, but comparative data in pregnant women are limited. We assessed the safety and activity profile of these two drugs in pregnancy using data from a national observational study. Methods: Women …

it (code pays fourni par la source)

Pregnant with HIV before age 25: data from a large national study in Italy, 2001–2016

Marco Floridia, Giulia Masuelli, Enrica Tamburrini, Irene Cetin et autres

Young pregnant women with HIV may be at significant risk of unplanned pregnancy, lower treatment coverage, and other adverse pregnancy outcomes. In a large cohort of pregnant women with HIV in Italy, among 2979 pregnancies followed in 2001-2016, 9·0% were in women …

it, us (code pays fourni par la source)

Evolving treatment implementation among HIV–infected pregnant women and their partners: results from a national surveillance study in Italy, 2001–2015

Marco Floridia, Valentina Frisina, Marina Ravizza, Anna Maria Marconi et autres

BACKGROUND: The current global and national indications for antiretroviral treatment (ART, usually triple combination therapy) in adolescent and adults, including pregnant women, recommend early ART before immunologic decline, pre-exposure chemoprophylaxis (PrEP), and treatment of HIV-negative partners in serodiscordant couples. There is limited …

it (code pays fourni par la source)